Trials / Completed
CompletedNCT01858155
Phase I Dose Finding Study for Melatonin in Pediatric Oncology Patients With Relapsed Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- C17 Council · Academic / Other
- Sex
- All
- Age
- 2 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate dose escalation of melatonin in pediatric oncology patients with relapsed solid tumors. The purpose of this study is to determine the safety of melatonin at a dose up to 20 mg daily, as well as to determine the maximum tolerated dose of melatonin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Melatonin |
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-31
- First posted
- 2013-05-21
- Last updated
- 2019-01-31
Locations
5 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01858155. Inclusion in this directory is not an endorsement.